ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Randomized study of 30 days of resveratrol and caloric restriction on serum levels of sirtuin-1 in healthy subjects (2015)
Mansur, A. P.; Roggerio, A.; Goes, M. F. S.; Takada, J. Y.; Avakian, S. D.; Strunz, C. M. C.
Source: European Heart Journal. Conference titles: ESC Congress. Unidade: FM
Subjects: PREVENÇÃO DE DOENÇAS, ESTUDOS RANDOMIZADOS, ARTERIOSCLEROSE, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANSUR, A. P. et al. Randomized study of 30 days of resveratrol and caloric restriction on serum levels of sirtuin-1 in healthy subjects. European Heart Journal. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/849.full.pdf. Acesso em: 06 nov. 2024. , 2015
APA
Mansur, A. P., Roggerio, A., Goes, M. F. S., Takada, J. Y., Avakian, S. D., & Strunz, C. M. C. (2015). Randomized study of 30 days of resveratrol and caloric restriction on serum levels of sirtuin-1 in healthy subjects. European Heart Journal. London: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/849.full.pdf
NLM
Mansur AP, Roggerio A, Goes MFS, Takada JY, Avakian SD, Strunz CMC. Randomized study of 30 days of resveratrol and caloric restriction on serum levels of sirtuin-1 in healthy subjects [Internet]. European Heart Journal. 2015 ; 36 1152-1153.[citado 2024 nov. 06 ] Available from: http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/849.full.pdf
Vancouver
Mansur AP, Roggerio A, Goes MFS, Takada JY, Avakian SD, Strunz CMC. Randomized study of 30 days of resveratrol and caloric restriction on serum levels of sirtuin-1 in healthy subjects [Internet]. European Heart Journal. 2015 ; 36 1152-1153.[citado 2024 nov. 06 ] Available from: http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/849.full.pdf
Trabalho de evento-resumo periodico
Long-term outcomes of patients with coronary artery disease and type 2 diabetes mellitus with chronic kidney disease undergoing surgery, angioplasty, or medical treatment (2014)
Lima, E. G.; Hueb, W.; Rezende, P. C.; Garzillo, C. L.; Scudeler, T. L.; Favarato, D.; Costa, L. M. A.; Hueb, A. C.; Ramires, J. A. F.; Kalil Filho, R.
Source: European Heart Journal. Conference titles: ESC Congress. Unidade: FM
Subjects: ANGIOPLASTIA, CIRURGIA TORÁCICA, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, CORONARIOPATIA, ARTERIOSCLEROSE, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, E. G. et al. Long-term outcomes of patients with coronary artery disease and type 2 diabetes mellitus with chronic kidney disease undergoing surgery, angioplasty, or medical treatment. European Heart Journal. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://eurheartj.oxfordjournals.org/content/ehj/35/suppl_1/1.full.pdf. Acesso em: 06 nov. 2024. , 2014
APA
Lima, E. G., Hueb, W., Rezende, P. C., Garzillo, C. L., Scudeler, T. L., Favarato, D., et al. (2014). Long-term outcomes of patients with coronary artery disease and type 2 diabetes mellitus with chronic kidney disease undergoing surgery, angioplasty, or medical treatment. European Heart Journal. London: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://eurheartj.oxfordjournals.org/content/ehj/35/suppl_1/1.full.pdf
NLM
Lima EG, Hueb W, Rezende PC, Garzillo CL, Scudeler TL, Favarato D, Costa LMA, Hueb AC, Ramires JAF, Kalil Filho R. Long-term outcomes of patients with coronary artery disease and type 2 diabetes mellitus with chronic kidney disease undergoing surgery, angioplasty, or medical treatment [Internet]. European Heart Journal. 2014 ; 35 156.[citado 2024 nov. 06 ] Available from: http://eurheartj.oxfordjournals.org/content/ehj/35/suppl_1/1.full.pdf
Vancouver
Lima EG, Hueb W, Rezende PC, Garzillo CL, Scudeler TL, Favarato D, Costa LMA, Hueb AC, Ramires JAF, Kalil Filho R. Long-term outcomes of patients with coronary artery disease and type 2 diabetes mellitus with chronic kidney disease undergoing surgery, angioplasty, or medical treatment [Internet]. European Heart Journal. 2014 ; 35 156.[citado 2024 nov. 06 ] Available from: http://eurheartj.oxfordjournals.org/content/ehj/35/suppl_1/1.full.pdf
Trabalho de evento-resumo periodico
The metabolic syndrome is an idependent marker of the presence of subclinical atherosclerosis for all levels of risk indicated by Framingham scores in subjects with age between 29 and 75 years old (2004)
Santos, R.; Lerario, D.; Martinez, T.; Ramires, José Antônio Franchini; Carvalho, J. A. M.
Source: European Heart Journal. Conference titles: Congress of the European Society of Cardiology. Unidade: FM
Subjects: METABOLISMO (FISIOPATOLOGIA), ARTERIOSCLEROSE, CORONARIOPATIA, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, R. et al. The metabolic syndrome is an idependent marker of the presence of subclinical atherosclerosis for all levels of risk indicated by Framingham scores in subjects with age between 29 and 75 years old. European Heart Journal. London: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 06 nov. 2024. , 2004
APA
Santos, R., Lerario, D., Martinez, T., Ramires, J. A. F., & Carvalho, J. A. M. (2004). The metabolic syndrome is an idependent marker of the presence of subclinical atherosclerosis for all levels of risk indicated by Framingham scores in subjects with age between 29 and 75 years old. European Heart Journal. London: Faculdade de Medicina, Universidade de São Paulo.
NLM
Santos R, Lerario D, Martinez T, Ramires JAF, Carvalho JAM. The metabolic syndrome is an idependent marker of the presence of subclinical atherosclerosis for all levels of risk indicated by Framingham scores in subjects with age between 29 and 75 years old. European Heart Journal. 2004 ; 25( 124): 634.[citado 2024 nov. 06 ]
Vancouver
Santos R, Lerario D, Martinez T, Ramires JAF, Carvalho JAM. The metabolic syndrome is an idependent marker of the presence of subclinical atherosclerosis for all levels of risk indicated by Framingham scores in subjects with age between 29 and 75 years old. European Heart Journal. 2004 ; 25( 124): 634.[citado 2024 nov. 06 ]

USP Schools

ReP

Filtros

Authors

Subjects